Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: Blue chips edge higher amid Wall Street gains

3rd Jun 2025 17:06

(Alliance News) - London's FTSE 100 posted modest gains on Tuesday as US markets rose after encouraging US jobs data, helping offset weak mining stocks and lower growth forecasts from the OECD. Read More

LONDON BROKER RATINGS: Jefferies raises Hiscox, cuts Rio Tinto

3rd Jun 2025 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: FTSE 100 up as UK pushes for tariff reprieve

3rd Jun 2025 07:50

(Alliance News) - Stocks were called to open higher on Tuesday, following claims that trade talks between US President Donald Trump and Chinese President Xi Jinping are imminent. Read More

DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock

2nd Jun 2025 21:45

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News: Read More

LONDON MARKET OPEN: Stocks mixed as UK house price growth speeds up

2nd Jun 2025 09:04

(Alliance News) - Stock prices in London opened mixed on Monday, ahead of the UK's manufacturing PMI reading and following the government's announced commitments to defence spending. Read More

US FDA accepts new drug application for GSK's liver drug linerixibat

2nd Jun 2025 08:29

(Alliance News) - GSK PLC on Monday announced the US Food & Drug Administration has accepted for review the new drug application for its liver disease treatment, linerixibat. Read More

LONDON MARKET CLOSE: FTSE 100 rises despite tariff worries; M&G shines

30th May 2025 17:05

(Alliance News) - The FTSE 100 outperformed in a mixed day for European equities, after the US Court of Appeals temporarily reinstated Donald Trump's tariffs. Read More

GSK ends cUTI trial early as Spero joint product meets efficacy goal

28th May 2025 12:16

(Alliance News) - GSK PLC on Wednesday said it will stop a late-stage trial early for an investigational oral antibiotic to treat complicated urinary tract infections, or cUTIs, after the treatment showed positive results in an interim analysis. Read More

LONDON MARKET CLOSE: Stocks down before long weekend, Powell's speech

23rd May 2025 17:01

(Alliance News) - Stock prices in London closed in the red on Friday, following US President Donald Trump's renewed tariff threats against the EU and Apple. Read More

GSK hails positive EU opinion of blood cancer treatment Blenrep

23rd May 2025 12:49

(Alliance News) - GSK PLC on Friday said its drug Blenrep has received a "positive opinion" from the European Medicines Agency's Committee for Medicinal Products for Human Use. Read More

LONDON MARKET OPEN: European stocks rise as bond yields ease

23rd May 2025 08:56

(Alliance News) - European stocks opened higher on Friday, as a cooling of US yields calmed some investor nerves, while improved UK data boosted sterling. Read More

GSK's Nucala wins FDA approval for COPD with eosinophilic inflammation

23rd May 2025 08:27

(Alliance News) - GSK PLC on Thursday said the US Food & Drug Administration has approved its asthma drug Nucala as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease, or COPD, who have an eosinophilic phenotype. Read More

GSK wins approval in Japan for Blenrep combination as myeloma therapy

19th May 2025 08:20

(Alliance News) - GSK PLC on Monday said it has received approval in Japan for Blenrep combinations in the treatment of adults with relapsed or refractory multiple myeloma. Read More

LONDON MARKET CLOSE: Stocks rise amid trade de-escalation boost

16th May 2025 17:01

(Alliance News) - The FTSE 100 pushed higher on Friday, ending the week on a strong note, and now at the level it roughly stood at prior to US President Donald Trump's 'liberation day' tariff melee. Read More

LONDON MARKET MIDDAY: FTSE 100 outperforms as Europe underwhelms

15th May 2025 12:13

(Alliance News) - London's FTSE 100 outperformed European peers, though a share price fall for oil majors and a host of other shares that went ex-dividend kept a lid on the blue-chip index's progress. Read More

LONDON BROKER RATINGS: RBC cuts AB Foods; JPMorgan raises Mondi

14th May 2025 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

GSK acquires "potential best-in-class" medicine efimosfermin

14th May 2025 09:13

(Alliance News) - GSK announced on Wednesday that it has agreed with Boston Pharmaceuticals to buy steatotic liver disease medication efimosfermin alfa. Read More

LONDON BRIEFING: Burberry swings to loss; H&T agrees terms of takeover

14th May 2025 07:53

(Alliance News) - London's FTSE was called down on Wednesday following criticisms from China on the US-UK trade deal being detrimental to third-party interests, and new threats from Europe for sanctions on Russia if a ceasefire in Ukraine is not reached. Read More

GSK ends development of potential cancer treatment belrestotug

13th May 2025 13:17

(Alliance News) - GSK PLC on Tuesday said it is ending the development programme for monoclonal antibody belrestotug. Read More

UK dividends calendar - next 7 days

8th May 2025 14:04

Read More

FTSE 100 Latest
Value9,100.77
Change-63.54